Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab

RTOG 0839 is a Phase II study of pre-operative chemoradiotherapy with or without panitumumab in potentially operable locally advanced non-small cell lung cancer (NSCLC). The investigational agent, panitumumab, is an anti-epithelial growth factor receptor (EGFR) antibody that improves progression-fre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zaorsky, Nicholas G, Sun, Yunguang, Wang, Zixuan, Palmer, Joshua, Fortina, Paolo M, Solomides, Charalambos, Werner-Wasik, Maria, Dicker, Adam P, Axelrod, Rita, Campling, Barbara, Evans III, Nathaniel, Cowan, Scott, Lu, Bo
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Bedside to Bench Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3926884/
https://ncbi.nlm.nih.gov/pubmed/23917487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.25942
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados